Insufficient scRNA-seq data for expression of FRS3 at single-cell level.
Insufficient scRNA-seq data for expression of FRS3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 716.73 | 180 / 180 | 100% | 9.33 | 430 / 430 |
brain | 100% | 1676.35 | 2640 / 2642 | 100% | 16.16 | 705 / 705 |
thymus | 100% | 1111.57 | 652 / 653 | 100% | 11.60 | 605 / 605 |
prostate | 100% | 756.69 | 244 / 245 | 99% | 10.83 | 499 / 502 |
uterus | 100% | 953.00 | 170 / 170 | 99% | 9.39 | 453 / 459 |
adrenal gland | 100% | 594.23 | 257 / 258 | 99% | 13.50 | 227 / 230 |
breast | 100% | 642.00 | 458 / 459 | 98% | 7.32 | 1097 / 1118 |
intestine | 100% | 720.42 | 964 / 966 | 98% | 6.57 | 517 / 527 |
bladder | 100% | 798.52 | 21 / 21 | 97% | 7.73 | 490 / 504 |
kidney | 100% | 592.53 | 89 / 89 | 97% | 6.48 | 875 / 901 |
stomach | 99% | 504.83 | 355 / 359 | 97% | 6.62 | 278 / 286 |
pancreas | 96% | 351.23 | 316 / 328 | 99% | 8.37 | 177 / 178 |
lung | 96% | 553.61 | 554 / 578 | 98% | 8.09 | 1137 / 1155 |
esophagus | 95% | 592.65 | 1367 / 1445 | 96% | 6.22 | 176 / 183 |
skin | 88% | 305.71 | 1589 / 1809 | 99% | 8.40 | 468 / 472 |
liver | 87% | 268.92 | 196 / 226 | 91% | 4.93 | 370 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.63 | 29 / 29 |
spleen | 100% | 705.18 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.37 | 1 / 1 |
blood vessel | 100% | 594.25 | 1329 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 7.62 | 79 / 80 |
adipose | 99% | 601.16 | 1187 / 1204 | 0% | 0 | 0 / 0 |
muscle | 97% | 454.33 | 781 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 442.72 | 833 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 5.98 | 42 / 45 |
peripheral blood | 40% | 108.31 | 368 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005104 | Molecular function | fibroblast growth factor receptor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0005068 | Molecular function | transmembrane receptor protein tyrosine kinase adaptor activity |
Gene name | FRS3 |
Protein name | Fibroblast growth factor receptor substrate 3 (Testicular tissue protein Li 71) Fibroblast growth factor receptor substrate 3 (FGFR substrate 3) (FGFR-signaling adaptor SNT2) (Suc1-associated neurotrophic factor target 2) (SNT-2) Fibroblast growth factor receptor substrate 3 |
Synonyms | hCG_1779355 |
Description | FUNCTION: Adapter protein that links FGF and NGF receptors to downstream signaling pathways. Involved in the activation of MAP kinases. Down-regulates ERK2 signaling by interfering with the phosphorylation and nuclear translocation of ERK2. . |
Accessions | O43559 ENST00000259748.6 ENST00000426290.1 ENST00000422888.5 A0A0A0MSM8 A6PVU0 A0A140VJJ7 ENST00000373018.7 |